BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 3622948)

  • 1. Studies on the gastroprotective and ulcer-healing effects of colloidal bismuth subcitrate.
    Konturek SJ; Radecki T; Piastucki I; Drozdowicz D
    Digestion; 1987; 37 Suppl 2():8-15. PubMed ID: 3622948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastrocytoprotection by colloidal bismuth subcitrate (De-Nol) and sucralfate. Role of endogenous prostaglandins.
    Konturek SJ; Radecki T; Piastucki I; Brzozowski T; Drozdowicz D
    Gut; 1987 Feb; 28(2):201-5. PubMed ID: 3470240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in the understanding of the mechanism of cytoprotective action by colloidal bismuth subcitrate.
    Konturek SJ; Radecki T; Piastucki I; Drozdowicz D
    Scand J Gastroenterol Suppl; 1986; 122():6-10. PubMed ID: 3465028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidermal growth factor (EGF) in the gastroprotective and ulcer healing actions of colloidal bismuth subcitrate (De-Nol) in rats.
    Konturek SJ; Dembinski A; Warzecha Z; Bielanski W; Brzozowski T; Drozdowicz D
    Gut; 1988 Jul; 29(7):894-902. PubMed ID: 3260885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gastric mucosa protective effects of colloidal bismuth subcitrate (DE-NOL).
    Hall DW; van den Hoven WE
    Int J Tissue React; 1987; 9(5):427-32. PubMed ID: 3478321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gastric mucosa protection and prostaglandin E2 generation in rats by colloidal bismuth subcitrate (DE-NOL).
    Hall DW; van den Hoven WE
    Arch Int Pharmacodyn Ther; 1987 Apr; 286(2):308-19. PubMed ID: 3473983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mucosa protectives: sucralfate and colloidal bismuth subcitrate in peptic ulcer disease.
    Tytgat GN; Nio CY
    Z Gastroenterol; 1987 Aug; 25 Suppl 3():152-61. PubMed ID: 3660894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibroblast growth factor in gastroprotection and ulcer healing: interaction with sucralfate.
    Konturek SJ; Brzozowski T; Majka J; Szlachcic A; Bielanski W; Stachura J; Otto W
    Gut; 1993 Jul; 34(7):881-7. PubMed ID: 8344573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytoprotective and ulcer healing properties of prostaglandin E2, colloidal bismuth and sucralfate in rats.
    Konturek SJ; Stachura J; Radecki T; Drozdowicz D; Brzozowski T
    Digestion; 1987; 38(2):103-13. PubMed ID: 3126091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nitric oxide in gastroprotective and ulcer healing effects of sucralfate.
    Konturek SJ; Brzozowski T; Pytko-Polonczyk J
    Scand J Gastroenterol Suppl; 1995; 210():22-7. PubMed ID: 8578200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Protective effect of colloidal bismuth subcitrate on gastric mucosal lesion induced by aspirin].
    Chen SP; Chen J; Wen SH
    Zhonghua Nei Ke Za Zhi; 1990 May; 29(5):293-5, 318. PubMed ID: 2242692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mucosal ulcerogenic action of monochloramine in rat stomachs: effects of polaprezinc and sucralfate.
    Kato S; Nishiwaki H; Konaka A; Takeuchi K
    Dig Dis Sci; 1997 Oct; 42(10):2156-63. PubMed ID: 9365151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topically active drugs in the treatment of peptic ulcers. Focus on colloidal bismuth subcitrate and sucralfate.
    Bianchi Porro G; Parente F
    J Clin Gastroenterol; 1992 Apr; 14(3):192-8. PubMed ID: 1348753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SU-840, a novel synthetic flavonoid derivative of sophoradin, with potent gastroprotective and ulcer healing activity.
    Brzozowski T; Konturek SJ; Kwiecien S; Pajdo R; Drozdowicz D; Sliwowski Z; Muramatsu M
    J Physiol Pharmacol; 1998 Mar; 49(1):83-98. PubMed ID: 9594413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Colloidal bismuth subcitrate in peptic ulcer--a review.
    Tytgat GN
    Digestion; 1987; 37 Suppl 2():31-41. PubMed ID: 3305117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sucralfate and other non-antisecretory agents in the treatment of peptic ulcer disease.
    May B
    Methods Find Exp Clin Pharmacol; 1989; 11 Suppl 1():113-6. PubMed ID: 2657280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Healing of chronic antral gastritis: effect of sucralfate and colloidal bismuth subcitrate.
    Kumar M; Yachha SK; Aggarwal R; Shukla S; Pandey R; Prasad KN; Ayyagari A; Naik SR
    Indian J Gastroenterol; 1996 Jul; 15(3):90-3. PubMed ID: 8840633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [De-nol in NSAID-induced gastroduodenal lesions].
    Cataldo MG; D'Aiuto A; Bongiorno A
    Minerva Dietol Gastroenterol; 1990; 36(1):27-30. PubMed ID: 2186304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Therapy of peptic ulcer and chronic gastritis with bismuth salts].
    Rösch W
    Z Gastroenterol; 1987 Sep; 25 Suppl 4():34-40. PubMed ID: 3687149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective properties of colloidal bismuth subcitrate on gastric mucosa.
    Hall DW; van den Hoven WE
    Scand J Gastroenterol Suppl; 1986; 122():11-3. PubMed ID: 3465026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.